1
|
Chaudhary P, Gulati N, Gupta V, Garg R, Walia S, Dhawan I, Thakur B. COVID-19 pandemic - Cocktail of variants, a study from Northern India. J Family Med Prim Care 2024; 13:2449-2454. [PMID: 39027869 PMCID: PMC11254030 DOI: 10.4103/jfmpc.jfmpc_1107_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 12/08/2023] [Accepted: 02/02/2024] [Indexed: 07/20/2024] Open
Abstract
Context The aim of the study was to identify and monitor the circulating strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the samples received at our center and update the existing national and international genomic surveillance data. Introduction SARS-CoV-2 is no exception to the basic nature of the viruses ability to change and evolve. Since its first report in December 2019 from Wuhan, China, multiple variants of the virus have emerged and been reported. Five variants of concern have been recognized and reported by the Centers for Disease Control and Prevention, which are associated with variable degrees of transmissibility and mortality. Materials and Methods Nasopharyngeal and oropharyngeal swabs received in viral transport medium at the Viral Research Diagnostic Laboratory were processed for reverse transcription-polymerase chain reaction for SARS-CoV-2. Whole genome sequencing (WGS) was performed for selective positive samples using Oxford Nanopore sequencing technology, using MinKNOW software for data acquisition. Statistical Analysis The clades were assigned using Nextclade v2.4.1 software. The statistical analysis was calculated using OpenEpi version 3, an open-source calculator, and two by two. Results Variants reported over the study period included Alpha, Kappa, Delta, and Omicron. Delta dominated in the year 2021, while Omicron was the dominant variant in 2022. In both the dominant variants, asymptomatics contributed to around 30-40% of positives. Intensive care unit admissions and mortality were higher in the Delta variant, while vaccination history and travel history were higher in the patients with Omicron variant. Conclusion The trend tracking of these variants has been important in view of public health, enabling early interventions to control the spread of the disease and foresight in preparation for the situation.
Collapse
Affiliation(s)
- Preeti Chaudhary
- Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
| | - Neelam Gulati
- Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
| | - Varsha Gupta
- Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
| | - Rajni Garg
- CSIR Pool Scientist, IMTECH, Chandigarh, India
| | - Sohini Walia
- Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
| | - Isha Dhawan
- Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
| | | |
Collapse
|
2
|
Choudhury S, Dubey S, Zumu M, Mustafa P P M, Burma A, Kumar S. The Role of Platelet Parameters in Predicting the Disease Severity of COVID-19 Patients: A Hospital-Based Study. Cureus 2024; 16:e51523. [PMID: 38304674 PMCID: PMC10832966 DOI: 10.7759/cureus.51523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/02/2024] [Indexed: 02/03/2024] Open
Abstract
Background and objective Globally, a large number of people have been impacted by the extremely contagious coronavirus disease 2019 (COVID-19) infection, and several pieces of literature were published on hematological parameter changes in this infection, particularly focusing on leucocytes. In this study, we have analyzed the platelet parameters and platelet-leucocyte ratios in COVID-19 patients and correlated them with the disease severity. Methods The COVID-19 patients who were hospitalized during the second peak of the pandemic were assessed. The platelet count and indices, platelet to lymphocyte ratio (PLR), neutrophil to platelet ratio (NPR), and clinical severity of each patient were analyzed. The significance of parameters and clinical severity was evaluated using analysis of variance (ANOVA) and the Kruskal Wallis test. A bivariate analysis was performed to assess the strength of the association. Receiver operating characteristic (ROC) curves were plotted to detect the predictive value of parameters for disease severity. Results The data of 132 COVID-19 patients has been evaluated. The average mean age was 45.60 ± 15.76 years with slight female predominance. Thrombocytopenia was found in 33% of cases with the majority of them being mild. Age, platelet distribution width (PDW), and PLR and NPR parameters were significantly (p-value <0.05) associated with disease severity. ROC curves showed age, PDW, PLR, NPR, absolute neutrophil count (ANC), and absolute lymphocyte count (ALC) had significant prediction values for clinical severity. Conclusions Platelet parameters may not accurately reflect the severity of the disease, but when combined with leucocyte parameters and their ratios (PLR and NPR), they offer important information about disease severity.
Collapse
Affiliation(s)
- Sampa Choudhury
- Department of Pathology, Andaman & Nicobar Islands Institute of Medical Sciences, Port Blair, IND
| | - Suparna Dubey
- Department of Pathology, School of Medical Sciences & Research, Sharda University, Greater Noida, IND
| | - Mhasisielie Zumu
- Department of Medical Gastroenterology, The Madras Medical Mission Hospital, Chennai, IND
| | - Mohammed Mustafa P P
- Department of General Surgery, Andaman & Nicobar Islands Institute of Medical Sciences, Port Blair, IND
| | - Amrita Burma
- Department of Community Medicine, Andaman & Nicobar Islands Institute of Medical Sciences, Port Blair, IND
| | - Saurabh Kumar
- School of Medicine, Andaman & Nicobar Islands Institute of Medical Sciences, Port Blair, IND
| |
Collapse
|
3
|
Dash A, Salkar A, Nissa MU, Makwana P, Athalye A, Parikh S, Srivastava S, Parikh F. Semen proteomics reveals alterations in fertility-related proteins post-recovery from COVID-19. Front Physiol 2023; 14:1212959. [PMID: 38028760 PMCID: PMC10665489 DOI: 10.3389/fphys.2023.1212959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Accepted: 10/24/2023] [Indexed: 12/01/2023] Open
Abstract
Introduction: Changes to sperm quality and decline in reproductive function have been reported in COVID-19-recovered males. Further, the emergence of SARS-CoV-2 variants has caused the resurgences of COVID-19 cases globally during the last 2 years. These variants show increased infectivity and transmission along with immune escape mechanisms, which threaten the already burdened healthcare system. However, whether COVID-19 variants induce an effect on the male reproductive system even after recovery remains elusive. Methods: We used mass-spectrometry-based proteomics approaches to understand the post-COVID-19 effect on reproductive health in men using semen samples post-recovery from COVID-19. The samples were collected between late 2020 (1st wave, n = 20), and early-to-mid 2021 (2nd wave, n = 21); control samples were included (n = 10). During the 1st wave alpha variant was prevalent in India, whereas the delta variant dominated the second wave. Results: On comparing the COVID-19-recovered patients from the two waves with control samples, using one-way ANOVA, we identified 69 significantly dysregulated proteins among the three groups. Indeed, this was also reflected by the changes in sperm count, morphology, and motility of the COVID-19- recovered patients. In addition, the pathway enrichment analysis showed that the regulated exocytosis, neutrophil degranulation, antibacterial immune response, spermatogenesis, spermatid development, regulation of extracellular matrix organization, regulation of peptidase activity, and regulations of calcium ion transport were significantly dysregulated. These pathways directly or indirectly affect sperm parameters and function. Our study provides a comprehensive landscape of expression trends of semen proteins related to male fertility in men recovering from COVID-19. Discussion: Our study suggests that the effect of COVID-19 on the male reproductive system persists even after recovery from COVID-19. In addition, these post-COVID-19 complications persist irrespective of the prevalent variants or vaccination status.
Collapse
Affiliation(s)
- Ankita Dash
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India
| | - Akanksha Salkar
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India
| | - Mehar Un Nissa
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India
| | - Prashant Makwana
- Department of Assisted Reproduction and Genetics, Jaslok-FertilTree International Centre, Jaslok Hospital and Research Centre, Mumbai, India
| | - Arundhati Athalye
- Department of Assisted Reproduction and Genetics, Jaslok-FertilTree International Centre, Jaslok Hospital and Research Centre, Mumbai, India
| | - Swapneil Parikh
- Department of Assisted Reproduction and Genetics, Jaslok-FertilTree International Centre, Jaslok Hospital and Research Centre, Mumbai, India
| | - Sanjeeva Srivastava
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India
| | - Firuza Parikh
- Department of Assisted Reproduction and Genetics, Jaslok-FertilTree International Centre, Jaslok Hospital and Research Centre, Mumbai, India
| |
Collapse
|
4
|
Ma Y, Wang H, Huang Y, Chen C, Liang S, Ma M, He X, Cai K, Jiao Z, Chen L, Zhu B, Li K, Xie C, Luo L, Zhang Z. The Role of "Hierarchical and Classified Prevention and Control Measures (HCPC)" Strategy for SARS-CoV-2 Delta Variant in Guangzhou: A Modeling Study. J Epidemiol Glob Health 2023; 13:303-312. [PMID: 37258853 PMCID: PMC10231852 DOI: 10.1007/s44197-023-00108-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2022] [Accepted: 04/04/2023] [Indexed: 06/02/2023] Open
Abstract
BACKGROUND The Delta variant of SARS-COV-2 has replaced previously circulating strains around the world in 2021. Sporadic outbreaks of the Delta variant in China have posed a concern about how to properly respond to the battle against evolving COVID-19. Here, we analyzed the "hierarchical and classified prevention and control (HCPC)" measures strategy deployed during the recent Guangzhou outbreak. METHODS A modified susceptible-exposed-pre-symptomatic-infectious-recovered (SEPIR) model was developed and applied to study a range of different scenarios to evaluate the effectiveness of policy deployment. We simulated severe different scenarios to understand policy implementation and timing of implementation. Two outcomes were measured: magnitude of transmission and duration of transmission. The outcomes of scenario evaluations were presented relative to the reality case (i.e., 368 cases in 34 days) with 95% confidence interval (CI). RESULTS Based on our simulation, the outbreak would become out of control with 7 million estimated infections under the assumption of the absence of any interventions than the 153 reported cases in reality in Guangzhou. The simulation on delayed implementation of interventions showed that the total case numbers would also increase by 166.67%-813.07% if the interventions were delayed by 3 days or 7 days. CONCLUSIONS It may be concluded that timely and more precise interventions including mass testing and graded community management are effective measures for Delta variant containment in China.
Collapse
Affiliation(s)
- Yu Ma
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
- Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
| | - Hui Wang
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
- Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
| | - Yong Huang
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
- Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
| | - Chun Chen
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
| | - Shihao Liang
- Yidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China
| | - Mengmeng Ma
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
- Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
| | - Xinjun He
- Yidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China
| | - Kangning Cai
- Yidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China
| | - Zengtao Jiao
- Yidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China
| | - Liyi Chen
- Yidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China
| | - Bowei Zhu
- Yidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China
| | - Ke Li
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China
| | - Chaojun Xie
- Guangzhou Huadu District Center for Disease Control and Prevention, Guangzhou, China
| | - Lei Luo
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
- Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
| | - Zhoubin Zhang
- Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
- Institute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
| |
Collapse
|
5
|
Triambak S, Mahapatra D, Barik N, Chutjian A. Plausible explanation for the third COVID-19 wave in India and its implications. Infect Dis Model 2023; 8:183-191. [PMID: 36643865 PMCID: PMC9824946 DOI: 10.1016/j.idm.2023.01.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 12/29/2022] [Accepted: 01/01/2023] [Indexed: 01/09/2023] Open
Abstract
Recently some of us used a random-walk Monte Carlo simulation approach to study the spread of COVID-19. The calculations were reasonably successful in describing secondary and tertiary waves of infection, in countries such as the USA, India, South Africa and Serbia. However, they failed to predict the observed third wave for India. In this work we present a more complete set of simulations for India, that take into consideration two aspects that were not incorporated previously. These include the stochastic movement of an erstwhile protected fraction of the population, and the reinfection of some recovered individuals because of their exposure to a new variant of the SARS-CoV-2 virus. The extended simulations now show the third COVID-19 wave for India that was missing in the earlier calculations. They also suggest an additional fourth wave, which was indeed observed during approximately the same time period as the model prediction.
Collapse
Affiliation(s)
- S. Triambak
- Department of Physics and Astronomy, University of the Western Cape, P/B X17, Bellville, 7535, South Africa,Corresponding author
| | - D.P. Mahapatra
- Department of Physics, Utkal University, Vani Vihar, Bhubaneshwar, 751004, India
| | - N. Barik
- Department of Physics, Utkal University, Vani Vihar, Bhubaneshwar, 751004, India
| | - A. Chutjian
- Armenian Engineers and Scientists of America, 326 Mira Loma Ave., Glendale, CA, 91204, USA
| |
Collapse
|
6
|
Ish P, Talukdar T, Sinha K. COVID-19 vaccine equity: the need of the hour. QJM 2023; 116:85. [PMID: 35092296 PMCID: PMC9383366 DOI: 10.1093/qjmed/hcac023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Indexed: 11/13/2022] Open
Affiliation(s)
- P Ish
- From the Department of Pulmonary and Critical Care Medicine, Room number 638, Superspeciality Block, VMMC and Safdarjung Hospital, New Delhi-110029, India
- Address correspondence to Dr P. Ish, Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, Room No. 638, 6th floor, Superspeciality Block, Delhi 110029, India.
| | - T Talukdar
- Department of Pulmonary Medicine, Lady Hardinge Medical College, New Delhi-110001, India
| | - K Sinha
- Department of Pulmonary Medicine, Lady Hardinge Medical College, New Delhi-110001, India
| |
Collapse
|
7
|
Goyal M, Ray I, Mascarenhas D, Kunal S, Sachdeva RA, Ish P. Myocarditis post-SARS-CoV-2 vaccination: a systematic review. QJM 2023; 116:7-25. [PMID: 35238384 PMCID: PMC8903459 DOI: 10.1093/qjmed/hcac064] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2022] [Revised: 02/24/2022] [Accepted: 02/26/2022] [Indexed: 01/07/2023] Open
Abstract
Variable clinical criteria taken by medical professionals across the world for myocarditis following coronavirus disease 2019 (COVID-19) vaccination along with wide variation in treatment necessitates understanding and reviewing the same. A systematic review was conducted to elucidate the clinical findings, laboratory parameters, treatment and outcomes of individuals with myocarditis after COVID-19 vaccination after registering with PROSPERO. Electronic databases including MEDLINE, EMBASE, PubMed, LitCovid, Scopus, ScienceDirect, Cochrane Library, Google Scholar and Web of Science were searched. A total of 85 articles encompassing 2184 patients were analysed. It was a predominantly male (73.4%) and young population (mean age: 25.5 ± 14.2 years) with most having taken an mRNA-based vaccine (99.4%). The mean duration from vaccination to symptom onset was 4.01 ± 6.99 days. Chest pain (90.1%), dyspnoea (25.7%) and fever (11.9%) were the most common symptoms. Only 2.3% had comorbidities. CRP was elevated in 83.3% and cardiac troponin in 97.6% patients. An abnormal ECG was reported in 979/1313 (74.6%) patients with ST-segment elevation being most common (34.9%). Echocardiographic data were available for 1243 patients (56.9%), of whom 288 (23.2%) had reduced left ventricular ejection fraction. Non-steroidal antiinflammatory drugs (76.5%), steroids (14.1%) followed by colchicine (7.3%) were used for treatment. Only 6 patients died among 1317 of whom data were available. Myocarditis following COVID-19 vaccination is often mild, seen more commonly in young healthy males and is followed by rapid recovery with conservative treatment. The emergence of this adverse event calls for harmonizing case definitions and definite treatment guidelines, which require wider research.
Collapse
Affiliation(s)
- Medha Goyal
- Department of Neonatology, Seth GSMC & KEMH, India, Mumbai
| | - Ishita Ray
- Department of Medicine, Mahatma Gandhi Memorial Medical College, Indore, Madhya Pradesh, India
| | | | - Shekhar Kunal
- Department of Cardiology, ESIC Medical College & Hospital Faridabad, India
| | - Ruchi Arora Sachdeva
- Department of Respiratory Medicine, ESIC Medical College & Hospital Faridabad, India
| | - Pranav Ish
- Corresponding author: Dr Pranav Ish, Assistant Professor, Department of Pulmonary and Critical Care Medicine, Room number 638. Superspeciality Block, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi 110029, India. , Phone- +91-9958356000
| |
Collapse
|
8
|
Bhattacharya M, Chatterjee S, Sharma AR, Lee SS, Chakraborty C. Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape. Folia Microbiol (Praha) 2023; 68:17-28. [PMID: 35962276 PMCID: PMC9374302 DOI: 10.1007/s12223-022-01001-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 08/07/2022] [Indexed: 12/01/2022]
Abstract
The Delta variant is one of the alarming variants of the SARS-CoV-2 virus that have been immensely detrimental and a significant cause of the prolonged pandemic (B.1.617.2). During the SARS-CoV-2 pandemic from December 2020 to October 2021, the Delta variant showed global dominance, and afterwards, the Omicron variant showed global dominance. Delta shows high infectivity rate which accounted for nearly 70% of the cases after December 2020. This review discusses the additional attributes that make the Delta variant so infectious and transmissible. The study also focuses on the significant mutations, namely the L452R and T478K present on the receptor-binding domain of spike (S)-glycoprotein, which confers specific alterations to the Delta variant. Considerably, we have also highlighted other notable factors such as the immune escape, infectivity and re-infectivity, vaccine escape, Ro number, S-glycoprotein stability, cleavage pattern, and its binding affinity with the host cell receptor protein. We have also emphasized clinical manifestations, symptomatology, morbidity, and mortality for the Delta variant compared with other significant SARS-CoV-2 variants. This review will help the researchers to get an elucidative view of the Delta variant to adopt some practical strategies to minimize the escalating spread of the SARS-CoV-2 Delta variant.
Collapse
Affiliation(s)
- Manojit Bhattacharya
- Department of Zoology, Fakir Mohan University, Vyasa Vihar, Balasore-756020, Odisha, India
| | - Srijan Chatterjee
- Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, 700126, India
| | - Ashish Ranjan Sharma
- Institute for Skeletal Aging & Orthopaedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon-si, 24252, Gangwon-do, Republic of Korea
| | - Sang-Soo Lee
- Institute for Skeletal Aging & Orthopaedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon-si, 24252, Gangwon-do, Republic of Korea
| | - Chiranjib Chakraborty
- Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, 700126, India.
| |
Collapse
|
9
|
Sanyaolu A, Marinkovic A, Prakash S, Okorie C, Jan A, Desai P, Fahad Abbasi A, Mangat J, Hosein Z, Hamdy K, Haider N, Khan N, Annan R, Badaru O, Izurieta R, Smith S. Perspective Chapter: SARS-CoV-2 Variants - Two Years Post-Onset of the Pandemic. Infect Dis (Lond) 2022. [DOI: 10.5772/intechopen.105913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Since the pandemic began in China in December 2019, thousands of variants of SARS-CoV-2 have emerged globally since late 2020. The World Health Organization (WHO) defined the SARS-CoV-2 variant of concern (VOC) as a variant with increased transmissibility, virulence, and decreased response to available diagnostics, vaccines, and therapeutics. Areas of the emerging variant of concern arise from countries like the United Kingdom, South Africa, Brazil, and India. These mutations carry a lineage from N501Y, D614G, N439K, Y453F, and others, which are globally dominated by clades 20A, 20B, and 20C. SARS-CoV-2 VOC emerged after 11 months of evolution since the onset through massive human-to-human transmission with five major VOCs recognized by the WHO, namely Alpha, Beta, Gamma, Delta, and Omicron. Their emergence could be attributed to changing immunological dynamics in the human population, which has resulted in resistance or escape from neutralizing antibodies, or to mutations and/or recombinations that increase transmission or pathogenicity. This literature review intends to identify and report on SARS-CoV-2 variants that have evolved two years post-onset of the pandemic and their disease implications.
Collapse
|
10
|
Ahluwalia B, Gupta NK, Singh A, Ish P, Dev N, Kohli S, Kumar R, Marwein F, Gupta N. Effect of COVID-19 vaccination status on outcome of adult patients admitted at a tertiary care centre in India. Monaldi Arch Chest Dis 2022; 93. [PMID: 35443571 DOI: 10.4081/monaldi.2022.2135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2021] [Accepted: 04/13/2022] [Indexed: 12/27/2022] Open
Abstract
COVID-19 vaccination was initially started in India on 16th January 2021 after approval from national authorities. This study was carried out to assess the effect of vaccination status on the severity and clinical outcome among patients infected with COVID-19. The study included all adult COVID-19 patients admitted to our hospital from 1st April to 30th June 2021. A total of 819 patients were enrolled in the study out of which only 183 (22.3%) were vaccinated. The study documented a statistically significant reduction in the severity of illness among the vaccinated (single/double dose) (33% severe COVID-19) against the unvaccinated (43% severe COVID-19) groups; along with a reduction in mortality. On univariate and multivariate analysis, age, severity of illness and lack of COVID-19 vaccination status were associated with a statistically significant increased mortality. To conclude, this study demonstrates the role of vaccination in decreasing the severity and mortality of COVID-19 infection.
Collapse
Affiliation(s)
- Bineet Ahluwalia
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi .
| | - Neeraj Kumar Gupta
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi .
| | - Amitabh Singh
- Department of Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi.
| | - Pranav Ish
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi .
| | - Nishanth Dev
- Department of Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi.
| | - Santvana Kohli
- Department of Anesthesiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi.
| | - Rohit Kumar
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi .
| | - Fellisha Marwein
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi .
| | - Nitesh Gupta
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi .
| |
Collapse
|
11
|
Abhilash KPP, Mathiyalagan P, Krishnaraj VRK, Selvan S, Kanagarajan R, Reddy NP, Rajendiran N, Hazra D, Gunasekaran K, Moorthy M, Jasmine S, Davis JP, George T, George K, Varghese GM, Rupali P, Barney Isaac T, Gupta R, Pichamuthu K, Joy M, Jayaseelan L, Mathews P, Peter JV. Impact of prior vaccination with Covishield TM and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study. Vaccine 2022; 40:2107-2113. [PMID: 35168837 PMCID: PMC8828422 DOI: 10.1016/j.vaccine.2022.02.023] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 02/02/2022] [Accepted: 02/03/2022] [Indexed: 12/27/2022]
Abstract
BACKGROUND COVID-19 vaccines were authorised for emergency use to mitigate the impact of the pandemic. This study evaluated the effect of prior vaccination with either Oxford Astra Zeneca's Covishield™ or Bharath Biotech's Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in India. METHODOLOGY In this cohort study comprising of RT-PCR confirmed symptomatic COVID-19 patients presenting during April and May 2021, the effect of prior vaccination on mortality (primary outcome), need for hospitalization, oxygen therapy, non-invasive ventilation (NIV) and intensive care unit (ICU) admission were assessed and expressed as risk ratio (RR) with 95% confidence intervals (CI). RESULTS The mean (SD) age of the cohort (n = 4183) was 46.3 (15.5) years; 17.9% (748/4183) had received at least one dose of Covishield™ and 4.8% (201/4183) had received Covaxin®. Mortality was 0.2% (95% CI: 0.2% - 0.7%), 3.5% (1.9-5.2%), 6.2% (0.3-12%) and 12.9% (11.8-14.1%) among fully vaccinated (>2 weeks after two doses), partially vaccinated (>2 weeks after one dose or <2 weeks after two doses), indeterminate (<2 weeks after one dose) and unvaccinated patients respectively. The difference in mortality among unvaccinated vs. fully vaccinated was 12.7% (95% CI: 11.4-13.9%), unvaccinated vs. partially vaccinated was 9.4% (7.4-11.4%) and unvaccinated vs. indeterminate vaccinated was 6.8% (0.8-12.7%). On adjusted analysis, as compared to unvaccinated patients, at least one dose of vaccine reduced the need for hospitalization (RR: 0.40; 95% CI: 0.35-0.47), oxygen (0.33; 0.27-0.40), NIV (0.23; 0.17-0.32), ICU admission (0.18; 0.12-0.27) and mortality (0.18; 0.11-0.29). CONCLUSION Among symptomatic COVID-19 patients, prior vaccination with Covishield ™ or Covaxin® impacted the severity of illness and reduced mortality during a period of widespread delta variant circulation. Full vaccination conferred greater protection than partial vaccination.
Collapse
Affiliation(s)
| | | | | | - Saravanan Selvan
- Department of Emergency Medicine, Christian Medical College, Vellore 632 004, India
| | - Rohini Kanagarajan
- Department of Emergency Medicine, Christian Medical College, Vellore 632 004, India
| | - Narmadha P. Reddy
- Department of Emergency Medicine, Christian Medical College, Vellore 632 004, India
| | - Natarajan Rajendiran
- Department of Emergency Medicine, Christian Medical College, Vellore 632 004, India
| | - Darpanarayan Hazra
- Department of Emergency Medicine, Christian Medical College, Vellore 632 004, India
| | - Karthik Gunasekaran
- Department of General Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India
| | - Mahesh Moorthy
- Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India
| | - Sudha Jasmine
- Department of General Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India
| | - John Prasad Davis
- Department of General Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India
| | - Tina George
- Department of General Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India
| | - Krupa George
- Department of General Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India
| | - George M. Varghese
- Department of Infectious Disease, Christian Medical College, Vellore 632004, Tamil Nadu, India
| | - Priscilla Rupali
- Department of Infectious Disease, Christian Medical College, Vellore 632004, Tamil Nadu, India
| | - T.J. Barney Isaac
- Department of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India
| | - Richa Gupta
- Department of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India
| | - Kishore Pichamuthu
- Division of Critical Care, Medical Intensive Care Unit, Christian medical College, Vellore 632004, India
| | - Melvin Joy
- Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India
| | | | - Prasad Mathews
- Department of Geriatric Medicine, Medical Superintendent, Christian Medical College, Vellore, India
| | - John Victor Peter
- Department of Critical Care, Christian Medical College, Vellore, India
| |
Collapse
|
12
|
Thakur S, Sasi S, Pillai SG, Nag A, Shukla D, Singhal R, Phalke S, Velu GSK. SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines. Front Med (Lausanne) 2022; 9:815389. [PMID: 35273977 PMCID: PMC8902153 DOI: 10.3389/fmed.2022.815389] [Citation(s) in RCA: 82] [Impact Index Per Article: 41.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Accepted: 01/04/2022] [Indexed: 12/11/2022] Open
Abstract
With the high rate of COVID-19 infections worldwide, the emergence of SARS-CoV-2 variants was inevitable. Several mutations have been identified in the SARS-CoV-2 genome, with the spike protein as one of the mutational hot spots. Specific amino acid substitutions such as D614G and N501Y were found to alter the transmissibility and virulence of the virus. The WHO has classified the variants identified with fitness-enhancing mutations as variants of concern (VOC), variants of interest (VOI) or variants under monitoring (VUM). The VOCs pose an imminent threat as they exhibit higher transmissibility, disease severity and ability to evade vaccine-induced and natural immunity. Here we review the mutational landscape on the SARS-CoV-2 structural and non-structural proteins and their impact on diagnostics, therapeutics and vaccines. We also look at the effectiveness of approved vaccines, antibody therapy and convalescent plasma on the currently prevalent VOCs, which are B.1.17, B.1.351, P.1, B.1.617.2 and B.1.1.529. We further discuss the possible factors influencing mutation rates and future directions.
Collapse
Affiliation(s)
- Suresh Thakur
- Trivitron Healthcare Pvt., Ltd., Visakhapatnam, India
| | - Shalitha Sasi
- Blue Horizon International Therapeutic Sciences, Hackensack, NJ, United States
| | | | | | - Dhananjay Shukla
- Department of Biotechnology, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India
| | - Ritu Singhal
- Department of Microbiology, National Institute of Tuberculosis and Respiratory Disease, New Delhi, India
| | - Sameer Phalke
- Trivitron Healthcare Pvt., Ltd., Visakhapatnam, India
| | - G. S. K. Velu
- Trivitron Healthcare Pvt., Ltd., Visakhapatnam, India
| |
Collapse
|
13
|
Ish P, Gaind R, Gupta N, Nath R, Srivastava N, Gahlot T, Gupta N. Effect of SARS-CoV-2 vaccination on severity and outcome of COVID-19 among health-care workers of a tertiary care hospital in India. INDIAN JOURNAL OF MEDICAL SPECIALITIES 2022. [DOI: 10.4103/injms.injms_56_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
14
|
Kunal S, Ray I, Ish P. Global implication of booster doses of COVID-19 vaccine. LE INFEZIONI IN MEDICINA 2021; 29:643-647. [PMID: 35146376 PMCID: PMC8805474 DOI: 10.53854/liim-2904-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/13/2021] [Accepted: 11/21/2021] [Indexed: 01/09/2023]
Affiliation(s)
- Shekhar Kunal
- Department of Cardiology. ESI Faridabad, Haryana, India
| | - Ishita Ray
- Mahatma Gandhi Memorial Medical College, Indore, Madhya Pradesh, India
| | - Pranav Ish
- Department of Pulmonary and Critical Care Medicine, VMMC and Safdarjung Hospital, New Delhi, India
| |
Collapse
|
15
|
Abstract
OBJECTIVE This paper investigates the relationship between the positivity rate and numbers of deaths and intensive care unit (ICU) patients. In addition, it explores the use of the positivity rate as an indicator for the spread of COVID-19. METHODS We used COVID-19 datasets for eight countries - Canada, USA, UK, Italy, Belgium, Ireland, Colombia and South Africa - and considered two correlation cases. The first case considers the correlation of the number of confirmed cases with each of deaths and ICU patients. The second case considers the correlation of the positivity rate with each of deaths and ICU patients. When obtaining the correlation, we considered different lagging periods between the date of confirming a case and the date of its ICU admittance or death. We compared the obtained correlation coefficient values for each of the two considered cases to explore whether the positivity rate is a better indicator for the spread of the disease than confirmed cases. For each of the eight considered countries, we obtained the daily reproduction number using each of confirmed cases and positivity rate. The two obtained sets of reproduction number values for each country were statistically compared to investigate whether they are significantly different. RESULTS When considering the daily positivity rate instead of the daily number of confirmed cases, the maximum correlation with deaths is increased by 349.9% for the USA (the country with the highest increase) and 4.5% for the UK (the country with the lowest increase), with an average increase of 60.8% considering the eight countries. Considering the daily positivity rate instead of the daily number of confirmed cases caused the maximum correlation with the number of ICU patients to be increased by 74.7% for the USA (the country with the highest increase) and 2.2% for the UK (the country with the lowest increase), with an average increase of 25% over the considered countries. The results for the daily reproduction number obtained using the positivity rate are statistically different from those obtained using daily confirmed cases. CONCLUSION The results indicate that positivity rate is a better indicator for the spread of the disease than the number of confirmed cases. Therefore, it is highly advised to use measures based on the positivity rate when indicating the spread of the disease and considering responses accordingly because these measures consider the daily number of tests and confirmed cases.
Collapse
Affiliation(s)
- Ahmed Al Dallal
- Department of Electrical and Computer Engineering, University of Alberta, Alberta, Canada
| | - Usama AlDallal
- School of Medicine, Royal College of Surgeons in Ireland - Medical University of Bahrain, Bahrain, Kingdom of Bahrain
| | - Jehad Al Dallal
- Computer Science Department, Gulf University for Science and Technology, Hawally, Kuwait
| |
Collapse
|
16
|
Nath R, Gupta NK, Jaswal A, Gupta S, Kaur N, Kohli S, Saxena A, Ish P, Kumar R, Tiwari P, Kumar M, Kishore J, Yadav G, Marwein F, Gupta N. Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India. Monaldi Arch Chest Dis 2021; 92. [PMID: 34634900 DOI: 10.4081/monaldi.2021.2034] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 09/10/2021] [Indexed: 11/23/2022] Open
Abstract
The similarities and differences between the mortality patterns of the two waves in India remain largely unknown. This was a retrospective study of medical records conducted in the COVID data center of our hospital This study analyzed data of patients who died in the month of August, 2020 to October 2020 (one month before and after the peak of first wave i.e., 16th September, 2020) & April 2021 to June 2021 (one month before and after the peak of second wave i.e., 6th May, 2021), corresponding to an equal part of the pandemic during first (2020) and second (2021) wave. Out of 1893 patients in the study, 764 patients were admitted during the first wave and 1129 patients during the second wave of pandemic. In total, 420 patients died during the entire study period. Of those, 147 (35%) deaths occurred during the first wave and 273 (65%) during the second wave, reflecting a case fatality rate (CFR) of 19.2% during the first wave and a CFR of 24.18%. There were no significant differences in the Age Group, Gender, Presenting Complaints, Duration of Stay and Comorbidities. However, the deceased COVID-19 patients had an increase in Case Fatality Rate, average duration of symptoms from onset to Hospital Admission (DOSHA) and a major shift from MODS to ARDS being the Cause of Death during the second wave of Pandemic. This study demonstrates increased CFR, average DOSHA and a paradigm shift to ARDS as cause of mortality during the second peak of the Pandemic. It is necessary to remain vigilant of newer COVID-19 variants of concern, follow COVID-19 appropriate behaviors and keep emphasizing on care of high-risk groups including patients with comorbidities and elderly population to prevent mortality.
Collapse
Affiliation(s)
- Ravindra Nath
- Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Neeraj Kumar Gupta
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Amandeep Jaswal
- Department of Anaesthesiology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Sparsh Gupta
- Department of Pharmacology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Navjot Kaur
- Department of Pharmacology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Santvana Kohli
- Department of Anaesthesiology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Anirudh Saxena
- Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Pranav Ish
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Rohit Kumar
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Poornima Tiwari
- Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Mukesh Kumar
- Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Jugal Kishore
- Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Geeta Yadav
- Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Fellisha Marwein
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| | - Nitesh Gupta
- Department of Pulmonary and Critical Care Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
| |
Collapse
|
17
|
Sharma N, Sharma P, Basu S, Bakshi R, Gupta E, Agarwal R, Dushyant K, Mundeja N, Marak Z, Singh S, Singh G, Rustagi R. Second Wave of the COVID-19 Pandemic in Delhi, India: High Seroprevalence Not a Deterrent? Cureus 2021; 13:e19000. [PMID: 34853742 PMCID: PMC8609204 DOI: 10.7759/cureus.19000] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/23/2021] [Indexed: 12/13/2022] Open
Abstract
Background We report the findings of a large follow-up, community-based, cross-sectional serosurvey and correlate it with the coronavirus disease (COVID-19) test-positivity rate and the caseload observed between the peaks of the first and the second wave of the COVID-19 pandemic in Delhi, India. Methodology Individuals aged five and above were recruited from 274 wards of the state (population approximately 19.6 million) from January 11 to January 22, 2021. A total of 100 participants each were included from all wards for a net sample size of approximately 28,000. A multistage sampling technique was employed to select participants for the household serosurvey. Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin (IgG) antibodies were detected by using the VITROS® (Ortho Clinical Diagnostics, Raritan, NJ, USA) assay (90% sensitivity, 100% specificity). Results Antibody positivity was observed in 14,298 (50.76%) of 28,169 samples. The age, sex, and district population-weighted seroprevalence of the SARS-CoV-2 IgG was 50.52% (95% confidence interval [CI] = 49.94-51.10), and after adjustment for assay characteristics, it was 56.13% (95% CI = 55.49-56.77). On adjusted analysis, participants aged ≥50 years, of female gender, housewives, having ever lived in containment zones, urban slum dwellers, and diabetes or hypertensive patients had significantly higher odds of SARS-CoV-2 antibody positivity. The peak infection rate and the test-positivity rate since October 2020 were initially observed in mid-November 2020, with a subsequent steep declining trend, followed by a period of persistently low case burden lasting until the first week of March 2021. This was followed by a steady increase followed by an exponential surge in infections from April 2021 onward culminating in the second wave of the pandemic. Conclusions The presence of infection-induced immunity from SARS-CoV-2 even in more than one in two people can be ineffective in protecting the population. Despite such high seroprevalence, population susceptibility to COVID-19 can be accentuated by variants of concern having the ability for rapid transmission and depletion of antibody levels with the threat of recurrent infections, signifying the need for mass vaccination.
Collapse
Affiliation(s)
- Nandini Sharma
- Community Medicine, Maulana Azad Medical College, New Delhi, IND
| | - Pragya Sharma
- Community Medicine, Maulana Azad Medical College, New Delhi, IND
| | - Saurav Basu
- Community Medicine, Maulana Azad Medical College, New Delhi, IND
| | - Ritika Bakshi
- Community Medicine, Maulana Azad Medical College, New Delhi, IND
| | - Ekta Gupta
- Department of Virology, Institute of Liver and Biliary Sciences, New Delhi, IND
| | - Reshu Agarwal
- Department of Virology, Institute of Liver and Biliary Sciences, New Delhi, IND
| | - Kumar Dushyant
- Community Medicine, Maulana Azad Medical College, New Delhi, IND
| | - Nutan Mundeja
- Director General Health Services, Directorate General of Health Services, Government of National Capital Territory, Delhi, New Delhi, IND
| | - Zeasaly Marak
- Public Health, Directorate General of Health Services, Government of National Capital Territory, Delhi, New Delhi, IND
| | - Sanjay Singh
- State Surveillance Unit, Directorate General of Health Services, Government of National Capital Territory, Delhi, New Delhi, IND
| | - Gautam Singh
- State Surveillance Unit, Directorate General of Health Services, Government of National Capital Territory, Delhi, New Delhi, IND
| | - Ruchir Rustagi
- State Surveillance Unit, Directorate of Family Welfare, Government of National Capital Territory, Delhi, New Delhi, IND
| |
Collapse
|
18
|
Pandrowala S, Ramraj D, Shankar R, Chopra S, Das A, Mishra A, Pandey D. Impact of preoperative COVID infection on the outcomes of planned curative-intent cancer surgeries in the second wave of the pandemic from a tertiary care center in India. J Surg Oncol 2021; 125:107-112. [PMID: 34569620 PMCID: PMC8662274 DOI: 10.1002/jso.26697] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 09/16/2021] [Accepted: 09/18/2021] [Indexed: 02/06/2023]
Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic was an unforeseen calamity. Sudden disruption of nonemergency services led to disruption of treatment across all specialties. Oncology revolves around the tenet of timely detection and treatment. Disruption of any sort will jeopardize cure rates. The time interval between coronavirus infection and cancer surgery is variable and needs to be tailored to avoid the progression of the disease. Methods We analyzed the impact of preoperative coronavirus disease 2019 (COVID‐19) infection on the planned cancer surgery, delay, disease progression, and change of intent of treatment from April 1 to May 31, 2021 at a tertiary care center. All preoperative positive patients were retested after 2 weeks and were considered for surgery if the repeat test was negative and asymptomatic. Findings Our study included 432 preoperative patients of which 91 (21%) were COVID‐19 positive. Amongst this cohort, 76% were operated and the morbidity and mortality were comparable to the COVID‐19 negative cohort. Around 10% of the COVID‐19 positive were lost to follow up and 10% had disease progression and were deemed palliative Interpretation SARS‐CoV‐2 infection has adversely impacted cancer care and a 2‐week waiting period postinfection seems to be a safe interval in asymptomatic individuals to consider radical cancer surgery.
Collapse
Affiliation(s)
- Saneya Pandrowala
- Department of Surgical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Tata Memorial Centre, Varanasi, Uttar Pradesh, India
| | - Deepak Ramraj
- Department of Surgical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Tata Memorial Centre, Varanasi, Uttar Pradesh, India
| | - Ravi Shankar
- Department of Surgical Oncology, Head and Neck Services, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Tata Memorial Centre, Varanasi, Uttar Pradesh, India
| | - Saumya Chopra
- Department of Surgical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Tata Memorial Centre, Varanasi, Uttar Pradesh, India
| | - Abhishek Das
- Department of Surgical Oncology, Head and Neck Services, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Tata Memorial Centre, Varanasi, Uttar Pradesh, India
| | - Aseem Mishra
- Department of Surgical Oncology, Head and Neck Services, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Tata Memorial Centre, Varanasi, Uttar Pradesh, India
| | - Durgatosh Pandey
- Department of Surgical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Tata Memorial Centre, Varanasi, Uttar Pradesh, India
| |
Collapse
|
19
|
Kirola L. Genetic emergence of B.1.617.2 in COVID-19. New Microbes New Infect 2021; 43:100929. [PMID: 34336227 PMCID: PMC8302888 DOI: 10.1016/j.nmni.2021.100929] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2021] [Revised: 07/16/2021] [Accepted: 07/19/2021] [Indexed: 02/07/2023] Open
Abstract
Many proactive steps have been taken worldwide to fight against the SARS-CoV-2 pandemic and to prevent COVID-19 spread with realistic approaches. Recently, a novel variant B.1.617.2 has been identified in India, which is rapidly transmitting to other countries, challenging current therapeutics, wide vaccination and future research in COIVD-19.
Collapse
Affiliation(s)
- L. Kirola
- Department of Molecular and Human Genetics, Banaras Hindu University, Varanasi, 221005, India
| |
Collapse
|
20
|
Ish P, Agrawal S, Sinha K. Tackling the roadblocks to COVID-19 vaccination in India - The need of the hour. Indian J Occup Environ Med 2021; 25:225-226. [PMID: 35197675 PMCID: PMC8815660 DOI: 10.4103/ijoem.ijoem_212_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2021] [Revised: 07/28/2021] [Accepted: 07/28/2021] [Indexed: 11/04/2022] Open
|